TLS-CHOP represses miR-486 expression, inducing upregulation of a metastasis regulator PAI-1 in human myxoid liposarcoma

Biochemical and Biophysical Research Communications

Volumn 427, Issue 2, 2012, Pages 355-360

  Borjigin, Nariso ^a   Ohno, Shinichiro ^a   Wu, Weihong ^a   Tanaka, Masami ^a   Suzuki, Rieko ^a   Fujita, Koji ^a   Takanashi, Masakatsu ^a   Oikawa, Kosuke ^a,b   Goto, Takahiro ^c   Motoi, Toru ^c   Kosaka, Taiichi ^a   Yamamoto, Kengo ^a   Kuroda, Masahiko ^a  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

^b WAKAYAMA MEDICAL UNIVERSITY   (Japan)

^c TOKYO METROPOLITAN KOMAGOME HOSPITAL   (Japan)

Author keywords

MiR 486; Myxoid liposarcoma; PAI 1; TLS CHOP

Indexed keywords

MICRORNA; MICRORNA 486; ONCOPROTEIN; ONCOPROTEIN TLS CHOP; PLASMINOGEN ACTIVATOR INHIBITOR 1; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DOWN REGULATION; FIBROBLAST; GENE EXPRESSION; HUMAN; HUMAN CELL; METASTASIS; MYXOSARCOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION;

ANIMALS; GENE KNOCKDOWN TECHNIQUES; HUMANS; LIPOSARCOMA, MYXOID; MICE; MICRORNAS; NEOPLASM METASTASIS; NIH 3T3 CELLS; ONCOGENE PROTEINS, FUSION; PLASMINOGEN ACTIVATOR INHIBITOR 1; RNA-BINDING PROTEIN FUS; TRANSCRIPTION FACTOR CHOP; UP-REGULATION;

EID: 84867858886     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.09.063     Document Type: Article

References (33)

1. Crozat A., Aman P., Mandahl N., Ron D. Fusion of CHOP to a novel RNA-binding protein in human myxoid liposarcoma. Nature 1993, 363:640-644.
2. Rabbitts T.H., Forster A., Larson R., Nathan P. Fusion of the dominant negative transcription regulator CHOP with a novel gene FUS by translocation t(12;16) in malignant liposarcoma. Nat. Genet. 1993, 4:175-180.
3. Powers M.P., Wang W.L., Hernandez V.S., Patel K.S., Lev D.C., Lazar A.J., Lopez-Terrada D.H. Detection of myxoid liposarcoma-associated FUS-DDIT3 rearrangement variants including a newly identified breakpoint using an optimized RT-PCR assay. Mod. Pathol. 2010, 23:1307-1315.
4. Perez-Losada J., Sanchez-Martin M., Rodriguez-Garcia M.A., Perez-Mancera P.A., Pintado B., Flores T., Battaner E., Sanchez-Garcia I. Liposarcoma initiated by FUS/TLS-CHOP: the FUS/TLS domain plays a critical role in the pathogenesis of liposarcoma. Oncogene 2000, 19:6015-6022.
5. Bento C., Andersson M.K., Aman P. DDIT3/CHOP and the sarcoma fusion oncoprotein FUS-DDIT3/TLS-CHOP bind cyclin-dependent kinase 2. BMC Cell Biol. 2009, 10:89.
6. Kuroda M., Wang X., Sok J., Yin Y., Chung P., Giannotti J.W., Jacobs K.A., Fitz L.J., Murtha-Riel P., Turner K.J., Ron D. Induction of a secreted protein by the myxoid liposarcoma oncogene. Proc. Natl. Acad. Sci. USA 1999, 96:5025-5030.
7. Andersson M.K., Goransson M., Olofsson A., Andersson C., Aman P. Nuclear expression of FLT1 and its ligand PGF in FUS-DDIT3 carrying myxoid liposarcomas suggests the existence of an intracrine signaling loop. BMC Cancer 2010, 10:249.
8. Perez-Mancera P.A., Bermejo-Rodriguez C., Sanchez-Martin M., Abollo-Jimenez F., Pintado B., Sanchez-Garcia I. FUS-DDIT3 prevents the development of adipocytic precursors in liposarcoma by repressing PPARgamma and C/EBPalpha and activating eIF4E. PLoS One 2008, 3:e2569.
9. Oikawa K., Tanaka M., Itoh S., Takanashi M., Ozaki T., Muragaki Y., Kuroda M. A novel oncogenic pathway by TLS-CHOP involving repression of MDA-7/IL-24 expression. Br. J. Cancer 2012.
10. Hwang H.W., Mendell J.T. MicroRNAs in cell proliferation, cell death and tumorigenesis. Br. J. Cancer 2006, 94:776-780.
11. Esquela-Kerscher A., Slack F.J. Oncomirs - microRNAs with a role in cancer. Nat. Rev. Cancer 2006, 6:259-269.
12. Oh H.K., Tan A.L., Das K., Ooi C.H., Deng N.T., Tan I.B., Beillard E., Lee J., Ramnarayanan K., Rha S.Y., Palanisamy N., Voorhoeve P.M., Tan P. Genomic loss of miR-486 regulates tumor progression and the OLFM4 antiapoptotic factor in gastric cancer. Clin. Cancer Res. 2011, 17:2657-2667.
13. Navon R., Wang H., Steinfeld I., Tsalenko A., Ben-Dor A., Yakhini Z. Novel rank-based statistical methods reveal microRNAs with differential expression in multiple cancer types. PLoS One 2009, 4:e8003.
14. Lijnen H.R. Pleiotropic functions of plasminogen activator inhibitor-1. J. Thromb. Haemost. 2005, 3:35-45.
15. Kwaan H.C., McMahon B. The role of plasminogen-plasmin system in cancer. Cancer Treat. Res. 2009, 148:43-66.
16. Andreasen P.A., Egelund R., Petersen H.H. The plasminogen activation system in tumor growth, invasion, and metastasis. Cell. Mol. Life Sci. 2000, 57:25-40.
17. Villadsen S.B., Bramsen J.B., Ostenfeld M.S., Wiklund E.D., Fristrup N., Gao S., Hansen T.B., Jensen T.I., Borre M., Orntoft T.F., Dyrskjot L., Kjems J. The miR-143/-145 cluster regulates plasminogen activator inhibitor-1 in bladder cancer. Br. J. Cancer 2012, 106:366-374.
18. Bajou K., Maillard C., Jost M., Lijnen R.H., Gils A., Declerck P., Carmeliet P., Foidart J.M., Noel A. Host-derived plasminogen activator inhibitor-1 (PAI-1) concentration is critical for in vivo tumoral angiogenesis and growth. Oncogene 2004, 23:6986-6990.
19. Nishioka N., Matsuoka T., Yashiro M., Hirakawa K., Olden K., Roberts J.D. Plasminogen activator inhibitor 1 RNAi suppresses gastric cancer metastasis in vivo. Cancer Sci. 2012, 103:228-232.
20. Zinszner H., Albalat R., Ron D. A novel effector domain from the RNA-binding protein TLS or EWS is required for oncogenic transformation by CHOP. Genes Dev. 1994, 8:2513-2526.
21. Morita S., Kojima T., Kitamura T. Plat-E: an efficient and stable system for transient packaging of retroviruses. Gene Ther. 2000, 7:1063-1066.
22. Tanaka M., Oikawa K., Takanashi M., Kudo M., Ohyashiki J., Ohyashiki K., Kuroda M. Down-regulation of miR-92 in human plasma is a novel marker for acute leukemia patients. PLoS One 2009, 4:e5532.
23. Suzuki R., Tanaka M., Takanashi M., Hussain A., Yuan B., Toyoda H., Kuroda M. Anthocyanidins-enriched bilberry extracts inhibit 3T3-L1 adipocyte differentiation via the insulin pathway. Nutr. Metab. (Lond.) 2011, 8:14.
24. Oikawa K., Yoshida K., Takanashi M., Tanabe H., Kiyuna T., Ogura M., Saito A., Umezawa A., Kuroda M. Dioxin interferes in chromosomal positioning through the aryl hydrocarbon receptor. Biochem. Biophys. Res. Commun. 2008, 374:361-364.
25. Tsuchida A., Ohno S., Wu W., Borjigin N., Fujita K., Aoki T., Ueda S., Takanashi M., Kuroda M. miR-92 is a key oncogenic component of the miR-17-92 cluster in colon cancer. Cancer Sci. 2011, 102:2264-2271.
26. Oikawa K., Ohbayashi T., Mimura J., Fujii-Kuriyama Y., Teshima S., Rokutan K., Mukai K., Kuroda M. Dioxin stimulates synthesis and secretion of IgE-dependent histamine-releasing factor. Biochem. Biophys. Res. Commun. 2002, 290:984-987.
27. Oikawa K., Ishida T., Imamura T., Yoshida K., Takanashi M., Hattori H., Ishikawa A., Fujita K., Yamamoto K., Matsubayashi J., Kuroda M., Mukai K. Generation of the novel monoclonal antibody against TLS/EWS-CHOP chimeric oncoproteins that is applicable to one of the most sensitive assays for myxoid and round cell liposarcomas. Am. J. Surg. Pathol. 2006, 30:351-356.
28. Kuroda M., Ishida T., Takanashi M., Satoh M., Machinami R., Watanabe T. Oncogenic transformation and inhibition of adipocytic conversion of preadipocytes by TLS/FUS-CHOP type II chimeric protein. Am. J. Pathol. 1997, 151:735-744.
29. Hammond S.M., Bernstein E., Beach D., Hannon G.J. An RNA-directed nuclease mediates post-transcriptional gene silencing in Drosophila cells. Nature 2000, 404:293-296.
30. Pillai R.S., Bhattacharyya S.N., Artus C.G., Zoller T., Cougot N., Basyuk E., Bertrand E., Filipowicz W. Inhibition of translational initiation by Let-7 MicroRNA in human cells. Science 2005, 309:1573-1576.
31. Karginov F.V., Conaco C., Xuan Z., Schmidt B.H., Parker J.S., Mandel G., Hannon G.J. A biochemical approach to identifying microRNA targets. Proc. Natl. Acad. Sci. USA 2007, 104:19291-19296.
32. Zhang X., Huang Q., Yang Z., Li Y., Li C.Y. GW112 a novel antiapoptotic protein that promotes tumor growth. Cancer Res. 2004, 64:2474-2481.
33. Chen Y., Kelm R.J., Budd R.C., Sobel B.E., Schneider D.J. Inhibition of apoptosis and caspase-3 in vascular smooth muscle cells by plasminogen activator inhibitor type-1. J. Cell. Biochem. 2004, 92:178-188.